Lantern Pharma Inc.
LTRN
$3.76
-$0.17-4.33%
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -3.74% | 2.60% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -4.23% | -5.64% | |||
| Operating Income | 4.23% | 5.64% | |||
| Income Before Tax | 9.15% | 8.85% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 9.15% | 8.85% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 9.15% | 8.85% | |||
| EBIT | 4.23% | 5.64% | |||
| EBITDA | 4.24% | 5.65% | |||
| EPS Basic | 9.20% | 8.98% | |||
| Normalized Basic EPS | 9.20% | 9.06% | |||
| EPS Diluted | 9.20% | 8.98% | |||
| Normalized Diluted EPS | 9.20% | 9.06% | |||
| Average Basic Shares Outstanding | 0.04% | 0.15% | |||
| Average Diluted Shares Outstanding | 0.04% | 0.15% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
